Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 4
1996 4
1997 4
1999 2
2000 3
2001 2
2002 1
2003 3
2004 4
2005 2
2006 2
2007 3
2008 7
2009 5
2010 3
2011 3
2012 5
2013 1
2014 1
2015 2
2016 2
2017 3
2018 3
2019 1
2020 6
2021 3
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Among authors: frankenberger m. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
Antiviral CD8+ T-cell immune responses are impaired by cigarette smoke and in COPD.
Chen J, Wang X, Schmalen A, Haines S, Wolff M, Ma H, Zhang H, Stoleriu MG, Nowak J, Nakayama M, Bueno M, Brands J, Mora AL, Lee JS, Krauss-Etschmann S, Dmitrieva A, Frankenberger M, Hofer TP, Noessner E, Moosmann A, Behr J, Milger K, Deeg CA, Staab-Weijnitz CA, Hauck SM, Adler H, Goldmann T, Gaede KI, Behrends J, Kammerl IE, Meiners S. Chen J, et al. Among authors: frankenberger m. Eur Respir J. 2023 Aug 3;62(2):2201374. doi: 10.1183/13993003.01374-2022. Print 2023 Aug. Eur Respir J. 2023. PMID: 37385655 Free PMC article.
Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis.
Leuschner G, Semenova A, Mayr CH, Kapellos TS, Ansari M, Seeliger B, Frankenberger M, Kneidinger N, Hatz RA, Hilgendorff A, Prasse A, Behr J, Mann M, Schiller HB. Leuschner G, et al. Among authors: frankenberger m. iScience. 2023 Oct 27;26(11):108345. doi: 10.1016/j.isci.2023.108345. eCollection 2023 Nov 17. iScience. 2023. PMID: 38026226 Free PMC article.
Monocyte signature as a predictor of chronic lung disease in the preterm infant.
Windhorst AC, Heydarian M, Schwarz M, Oak P, Förster K, Frankenberger M, Gonzalez Rodriguez E, Zhang X, Ehrhardt H, Hübener C, Flemmer AW, Hossain H, Stoeger T, Schulz C, Hilgendorff A. Windhorst AC, et al. Among authors: frankenberger m. Front Immunol. 2023 Apr 5;14:1112608. doi: 10.3389/fimmu.2023.1112608. eCollection 2023. Front Immunol. 2023. PMID: 37090732 Free PMC article.
Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment.
Kahnert K, Andreas S, Kellerer C, Lutter JI, Lucke T, Yildirim Ö, Lehmann M, Seissler J, Behr J, Frankenberger M, Bals R, Watz H, Welte T, Trudzinski FC, Vogelmeier CF, Alter P, Jörres RA; COSYCONET Study Group. Kahnert K, et al. Among authors: frankenberger m. Sci Rep. 2022 Jan 26;12(1):1435. doi: 10.1038/s41598-022-05276-x. Sci Rep. 2022. PMID: 35082306 Free PMC article.
Health effects of ambient particulate matter--biological mechanisms and inflammatory responses to in vitro and in vivo particle exposures.
Maier KL, Alessandrini F, Beck-Speier I, Hofer TP, Diabaté S, Bitterle E, Stöger T, Jakob T, Behrendt H, Horsch M, Beckers J, Ziesenis A, Hültner L, Frankenberger M, Krauss-Etschmann S, Schulz H. Maier KL, et al. Among authors: frankenberger m. Inhal Toxicol. 2008 Feb;20(3):319-37. doi: 10.1080/08958370701866313. Inhal Toxicol. 2008. PMID: 18300050 Review.
Asthma features in severe COPD: Identifying treatable traits.
Matthes S, Stadler J, Barton J, Leuschner G, Munker D, Arnold P, Villena-Hermoza H, Frankenberger M, Probst P, Koch A, Kneidinger N, Milger K, Behr J, Neurohr C. Matthes S, et al. Among authors: frankenberger m. Respir Med. 2018 Dec;145:89-94. doi: 10.1016/j.rmed.2018.10.027. Epub 2018 Oct 26. Respir Med. 2018. PMID: 30509722 Free article.
Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy.
Kammerl IE, Hardy S, Flexeder C, Urmann A, Peierl J, Wang Y, Vosyka O, Frankenberger M, Milger K, Behr J, Koch A, Merl-Pham J, Hauck SM, Pilette C, Schulz H, Meiners S. Kammerl IE, et al. Among authors: frankenberger m. Eur Respir J. 2022 Mar 3;59(3):2101798. doi: 10.1183/13993003.01798-2021. Print 2022 Mar. Eur Respir J. 2022. PMID: 34561290 Free PMC article.
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
Fischer DS, Ansari M, Wagner KI, Jarosch S, Huang Y, Mayr CH, Strunz M, Lang NJ, D'Ippolito E, Hammel M, Mateyka L, Weber S, Wolff LS, Witter K, Fernandez IE, Leuschner G, Milger K, Frankenberger M, Nowak L, Heinig-Menhard K, Koch I, Stoleriu MG, Hilgendorff A, Behr J, Pichlmair A, Schubert B, Theis FJ, Busch DH, Schiller HB, Schober K. Fischer DS, et al. Among authors: frankenberger m. Nat Commun. 2021 Jul 26;12(1):4515. doi: 10.1038/s41467-021-24730-4. Nat Commun. 2021. PMID: 34312385 Free PMC article.
82 results